A single birth dose of Hepatitis B vaccine induces polyfunctional CD4+ T helper cells

Front Immunol. 2022 Nov 8:13:1043375. doi: 10.3389/fimmu.2022.1043375. eCollection 2022.

Abstract

A single birth-dose of Hepatitis B vaccine (HepB) can protect newborns from acquiring Hepatitis B infection through vertical transmission, though several follow-up doses are required to induce long-lived protection. In addition to stimulating antibodies, a birth-dose of HepB might also induce polyfunctional CD4+ T-cells, which may contribute to initial protection. We investigated whether vaccination with HepB in the first week of life induced detectable antigen-specific CD4+ T-cells after only a single dose and following completion of the entire HepB vaccine schedule (3 doses). Using HBsAg- stimulated peripheral blood mononuclear cells from 344 infants, we detected increased populations of antigen-specific polyfunctional CD154+IL-2+TNFα+ CD4+ T-cells following a single birth-dose of HepB in a proportion of infants. Frequencies of polyfunctional T-cells increased following the completion of the HepB schedule but increases in the proportion of responders as compared to following only one dose was marginal. Polyfunctional T-cells correlated positively with serum antibody titres following the birth dose (day30) and completion of the 3-dose primary HepB vaccine series (day 128). These data indicate that a single birth dose of HepB provides immune priming for both antigen-specific B- and T cells.

Keywords: BCG; CD154; CD4 + T helper cell; Hepatitis B vaccine; T-cell activation; antibody titres; neonate.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes
  • Hepatitis B Vaccines*
  • Humans
  • Infant
  • Infant, Newborn
  • Leukocytes, Mononuclear*
  • T-Lymphocytes, Helper-Inducer

Substances

  • Hepatitis B Vaccines
  • gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide